Latest Conference Articles

July 6th 2022, 1:00pm

Educated Patient® Skin Cancer Summit: June 18, 2022

Watch Dr. Barbara Ma, from Weill Cornell Medicine, discuss the basics of basal and squamous cell carcinomas during the CURE Educated Patient Skin Cancer Summit.

July 5th 2022, 1:00pm

Educated Patient® Metastatic Breast Cancer Summit: June 11, 2022

Watch Emily Huskey, Dr. Wendy Baer, Fabienne Ehivet and Lisa Weems answer questions about areas outside of treatment during the CURE Educated Patient Metastatic Breast Cancer Summit.

July 4th 2022, 2:00pm

Educated Patient® Metastatic Breast Cancer Summit: June 11, 2022

Watch Fabienne Ehivet, from Emory Saint Joseph’s Hospital, discuss genetic testing, during the CURE Educated Patient Metastatic Breast Cancer Summit.

July 3rd 2022, 2:00pm

Educated Patient® Metastatic Breast Cancer Summit: June 11, 2022

Watch Dr. Wendy Baer, from Winship Cancer Institute at Emory University, discuss psychosocial issues, during the CURE Educated Patient Metastatic Breast Cancer Summit.

July 2nd 2022, 2:00pm

Educated Patient® Metastatic Breast Cancer Summit: June 11, 2022

Watch Emily Huskey, from the Winship Cancer Institute of Emory University, discuss diet and exercise, during the CURE Educated Patient Metastatic Breast Cancer Summit.

July 1st 2022, 1:00pm

Educated Patient® Metastatic Breast Cancer Summit: June 11, 2022

Watch Dr. Kimberly Curseen, Dr. Anna Bausum, Dr. Kevin Kalinsky and Alyncia Mason answer questions about additional care, during the CURE Educated Patient Metastatic Breast Cancer Summit.

June 30th 2022, 1:00pm

Educated Patient® Metastatic Breast Cancer Summit: June 11, 2022

Watch Dr. Kevin Kalinsky, from Winship Cancer Institute of Emory University, discuss joining clinical trials, during the CURE Educated Patient Metastatic Breast Cancer Summit.

June 29th 2022, 1:00pm

Educated Patient® Metastatic Breast Cancer Summit: June 11, 2022

Watch Dr. Anna Bausum, Winship Cancer Institute at Emroy University, discuss alternative medicine, during the CURE Educated Patient Metastatic Breast Cancer Summit.

June 28th 2022, 1:00pm

Educated Patient® Metastatic Breast Cancer Summit: June 11, 2022

Watch Dr. Kimberly Curseen, from Winship Cancer Institute of Emory University, discuss supportive care, during the CURE Educated Patient Metastatic Breast Cancer Summit.

June 27th 2022, 1:00pm

Educated Patient® Metastatic Breast Cancer Summit: June 11, 2022

Watch Dr. Suchita Pakkala, Dr. Jane Meisel, Dr. Keerthi Gogineni and Kelly Shanahan discuss updates in disease management during the CURE Educated Patient Metastatic Breast Cancer Summit.

June 24th 2022, 1:00pm

Educated Patient® Metastatic Breast Cancer Summit: June 11, 2022

Watch Dr. Suchita Pakkala, from Emory University School of Medicine, discuss estrogen receptor-positive disease, during the CURE Educated Patient Metastatic Breast Cancer Summit.

June 17th 2022, 1:00pm

Educated Patient® Prostate Cancer Summit: May 21, 2022

Watch Dr. Jeremie Calais, Dr. Tian Zhang, Dr. Landon C. Brown and Jim Rosenfield answer questions about novel agents and strategies during the CURE Educated Patient Prostate Cancer Summit.

June 16th 2022, 1:00pm

Educated Patient® Prostate Cancer Summit: May 21, 2022

Watch Dr. Landon C. Brown, from Atrium Health Levine Cancer Institute, discuss approaches to hormone therapy, during the CURE Educated Patient Prostate Cancer Summit.

June 15th 2022, 1:00pm

Educated Patient® Prostate Cancer Summit: May 21, 2022

Watch Dr. Tian Zhang, from UT Southwestern Medical Center, discuss novel agents, during the CURE Educated Patient Prostate Cancer Summit.

June 14th 2022, 1:00pm

Educated Patient® Prostate Cancer Summit: May 21, 2022

Watch Dr. Jeremie Calais, from UCLA, discuss novel imaging strategies, during the CURE Educated Patient Prostate Cancer Summit.

June 13th 2022, 9:00pm

Treatment with Venclexta plus Gazyva, with or without Imbruvica, led to better outcomes than chemoimmunotherapy in patients with chronic lymphocytic leukemia.

June 13th 2022, 1:00pm

Educated Patient® Prostate Cancer Summit: May 21, 2022

Watch Dr. Veda N. Giri, Dr. Umang Swami and Sue Friedman answer questions about genetics and genomics during the CURE Educated Patient Prostate Cancer Summit.

June 12th 2022, 2:00pm

Educated Patient® Prostate Cancer Summit: May 21, 2022

Watch Dr. Umang Swami, from Huntsman Cancer Institute, discuss genomic changes and PARP inhibitors, during the CURE Educated Patient Prostate Cancer Summit.

June 11th 2022, 2:00pm

Educated Patient® Prostate Cancer Summit: May 21, 2022

Watch Dr. Veda N. Giri, from Sidney Kimmel Cancer Center at Thomas Jefferson University, discuss genetic testing and who should get it, during the CURE Educated Patient Prostate Cancer Summit.

June 10th 2022, 9:00pm

ASCO Annual Meeting

Brukinsa, which was approved in September 2021, resulted in better ouctomes for certain patients with with Waldenström macroglobulinemia, according to the ASPEN clinical trial.

June 10th 2022, 7:00pm

ASCO Annual Meeting

Patients who underwent Revlimid, Velcade, and dexamethasone therapy followed by maintenance Revlimid, tended to have better outcomes when they underwent autologous stem cell transplant.

June 10th 2022, 1:00pm

Educated Patient® Prostate Cancer Summit: May 21, 2022

Watch Dr. Ganesh Raj, Dr. Andrew Z. Wang, and Bruce Williams, discuss treatment for localized disease, during the CURE Educated Patient Prostate Cancer Summit.

June 9th 2022, 7:00pm

The use of Jakafi plus chemotherapy shows promise in the pre- and post-surgical treatment settings for patients with stage 3 and 4 ovarian cancer, warranting further study of the combination.

June 9th 2022, 3:00pm

ASCO Annual Meeting

Keytruda, an immunotherapy agent, demonstrated significant improvement in both distant metastasis-free survival and recurrence-free survival compared to placebo.

June 9th 2022, 1:00pm

Educated Patient® Prostate Cancer Summit: May 21, 2022

Watch Dr. Andrew Z. Wang, from UT Southwestern Medical Center, discuss approaches to radiation for local disease, during the CURE Educated Patient Prostate Cancer Summit.

June 8th 2022, 9:00pm

After more than two years of follow-up, patients with previously untreated, locally advanced stage 3 non–small cell lung cancer continue to derive a benefit from treatment with Keytruda and chemoradiation.

June 8th 2022, 7:00pm

ASCO Annual Meeting

One-hundred percent of patients with stage 2/3 mismatch repair-deficient rectal cancer had their disease disappear after treatment with Jermperli, though more research and longer follow-up is needed.

June 8th 2022, 3:00pm

ASCO Annual Meeting

Although ineffective in patients with non-small cell lung cancer and brain metastases at diagnosis, treatment with Exkivity may benefit patients with EGFR exon 20 insertion-positive metastatic disease.

June 8th 2022, 1:00pm

Educated Patient® Prostate Cancer Summit: May 21, 2022

Watch Dr. Ganesh V. Raj, from UT Southwestern Medical Center, discuss surgery for localized disease, during the CURE Educated Patient Prostate Cancer Summit.

June 7th 2022, 9:00pm

The use of the chemotherapy ifosfamide was associated with small improvements in survival outcomes in a group of patients with relapsed/refractory Ewing sarcoma, a rare type of bone or soft tissue cancer.